Company Filing History:
Years Active: 2006
Title: Antonio Piga: Innovator in Cardiac Disease Treatment
Introduction
Antonio Piga is a notable inventor based in Moncalieri, Italy. He has made significant contributions to the field of medicine, particularly in the treatment of iron-induced cardiac diseases. His innovative approach has the potential to improve the quality of life for patients suffering from conditions such as thalassemia.
Latest Patents
Antonio Piga holds a patent for a method of treating iron-induced cardiac disease in patients with iron overload. The patent, titled "Use for deferiprone," describes a method that involves administering a therapeutically effective amount of deferiprone or a physiologically acceptable salt thereof. This treatment is designed to address the cardiac complications associated with iron overload.
Career Highlights
Antonio Piga is associated with Apotex Inc., a company known for its commitment to developing and manufacturing high-quality pharmaceuticals. His work at Apotex has allowed him to focus on innovative solutions for complex medical issues. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Antonio Piga collaborates with Michael Spino, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in advancing medical research and innovation.
Conclusion
Antonio Piga's contributions to the treatment of iron-induced cardiac diseases highlight his role as an influential inventor in the medical field. His innovative patent and collaboration with industry professionals underscore the importance of continued research and development in improving patient care.